08:40 AM EST, 11/05/2026 (MT Newswires) -- RBC Capital Markets on Thursday downgraded German drug containment and delivery systems company Schott Pharma (1SXP.F) to sector perform from outperform and raised its price target to 25 euros from 21 euros. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.